https://biopark.eeHome - BioParkTartu Biotechnology Park provides infrastructural, business development and consultancy services to companies and R&D institutions.
Name
ZipPrime OÜ
Registry code
14825945
VAT number
EE102233775
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
14.10.2019 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72111 - Research and experimental development on biotechnology
0 €
-1 454 €
-
-
1 234 €
0
Submitted
No tax arrears
-118%
-26%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Neil Ciaron Thomas 27.05.1971 (53) | 18% - 450.00 EUR | Board member | - | |
| Sven Parkel 29.01.1981 (43) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | Founder |
| 2020 28.06.2021 | 2021 26.04.2022 | 2022 07.06.2023 | 2023 08.02.2024 | |
|---|---|---|---|---|
| Total Revenue | - | - | 15 000 € | 0 € |
| Net profit (loss) for the period | -935 € | -957 € | 4 580 € | -1 454 € |
| Profit Margin | - | - | 31% | - |
| Current Assets | 238 € | 199 € | 5 762 € | 4 812 € |
| Fixed Assets | 2 263 € | 1 769 € | 1 276 € | 782 € |
| Total Assets | 2 501 € | 1 968 € | 7 038 € | 5 594 € |
| Current Liabilities | 3 436 € | 3 860 € | 4 350 € | 4 360 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -935 € | -1 892 € | 2 688 € | 1 234 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | 44 € | - | - |
| 2022 Q3 | 16 800 € | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | - | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
| 2020 Q4 | 2 468.63 € | - | - | - |
| 2020 Q3 | - | - | - | - |
| 2020 Q2 | - | - | - | - |
| 2020 Q1 | - | - | - | - |
